Quest Diagnostics Incorporated
US ˙ NYSE ˙ US74834L1008

SecurityDGX / Quest Diagnostics Incorporated
InstitutionBailard, Inc.
Latest Disclosed Ownership5,545 shares
Latest Disclosed Value $ 1,086,709
Bailard, Inc. reports 37.05% increase in ownership of DGX / Quest Diagnostics Incorporated

On May 11, 2026 - Bailard, Inc. filed a 13F-HR form disclosing ownership of 5,545 shares of Quest Diagnostics Incorporated (US:DGX) valued at $1,086,709 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 4,046 shares of Quest Diagnostics Incorporated. This represents a change in shares of 37.05% during the quarter. The current value of the position is $1,073,900 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F QUEST DIAGNOSTICS COM 74834L100 5,545 1,499 37.05 1,087 54.70 0.0250
2026-02-04 2025-12-31 13F QUEST DIAGNOSTICS COM 74834L100 4,046 4,046 702 0.0155
2021-08-13 2021-06-30 13F QUEST DIAGNOSTICS COM 74834L100 0 -2,668 -100.00 0 -100.00
2021-05-13 2021-03-31 13F QUEST DIAGNOSTICS COM 74834L100 2,668 -37,868 -93.42 342 -92.92 0.0127
2021-02-03 2020-12-31 13F QUEST DIAGNOSTICS COM 74834L100 40,536 378 0.94 4,831 5.07 0.2203
2020-11-10 2020-09-30 13F QUEST DIAGNOSTICS COM 74834L100 40,158 867 2.21 4,598 2.68 0.2381
2020-08-12 2020-06-30 13F QUEST DIAGNOSTICS COM 74834L100 39,291 3,995 11.32 4,478 58.01 0.2501
2020-04-16 2020-03-31 13F QUEST DIAGNOSTICS COM 74834L100 35,296 5,502 18.47 2,834 -10.94 0.2018
2020-01-31 2019-12-31 13F QUEST DIAGNOSTICS COM 74834L100 29,794 7,520 33.76 3,182 33.47 0.1793
2019-10-18 2019-09-30 13F QUEST DIAGNOSTICS COM 74834L100 22,274 1,709 8.31 2,384 13.85 0.1442
2019-07-26 2019-06-30 13F QUEST DIAGNOSTICS COM 74834L100 20,565 882 4.48 2,094 18.31 0.1280
2019-04-24 2019-03-31 13F QUEST DIAGNOSTICS COM 74834L100 19,683 -68 -0.34 1,770 7.60 0.1098
2019-02-05 2018-12-31 13F QUEST DIAGNOSTICS COM 74834L100 19,751 -14,664 -42.61 1,645 -55.71 0.1112
2018-11-13 2018-09-30 13F QUEST DIAGNOSTICS COM 74834L100 34,415 -476 -1.36 3,714 -3.18 0.2172
2018-08-08 2018-06-30 13F QUEST DIAGNOSTICS COM 74834L100 34,891 34,891 3,836 0.2285
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.